MKI67 and adenocarcinoma: Finally, dual immunofluorescence (IF) staining confirmed co-expression of STMN1 and Ki67 in both benign and adenocarcinoma prostate tissues (Fig. 5F), further supporting the association of STMN1 expression with a proliferative phenotype.